Rapid Micro Biosystems Inc - Ordinary Shares - Class A Aktie News

Berichtet für das zweite Quartal 2026 einen Gesamtumsatz von 8,1 Mio. USD, was einem Wachstum von 11 % gegenüber dem zweiten Quartal 2025 entspricht Meilenstein erreicht mit dem 200. weltweit platzierten Growth Direct-System; im zweiten Quartal 2026 wurden vier Growth Direct-Systeme platziert und neun Validierungen abgeschlossen Die Verbrauchsmaterialumsätze im zweiten Quartal stiegen gegenüber...

LEXINGTON, Mass., 04. Aug. 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (das „Unternehmen“), ein innovatives Life-Sciences-Technologieunternehmen, das missionskritische Automatisierungslösungen zur effizienten Herstellung und schnellen, sicheren Freigabe von Gesundheitsprodukten anbietet, gab heute die Zuteilungen am 3. Aug. 2026 von 90.000 Restricted Stock Units („RSUs“...

LEXINGTON, Mass., June 10, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced the grant on June 3, 2026, of 60,000 restricted stock units (“RSUs”) of the Company'...

Bain Capital Life Sciences and Armistice Capital are investing approximately $9.8 million, with the potential of up to approximately $32 million in the event the warrants offered in this offering are exercised, to support the future success of the Company. Certain directors and officers of the Company are also investing in a concurrent registered offering Bain Capital Life Sciences and Armistic...

Rapid Micro Biosystems NASDAQ: RPID reported first-quarter 2026 revenue growth and reaffirmed its full-year outlook, citing momentum in system placements, consumables and recurring revenue, while management said gross margin improvement remains a central priority for the year.

LEXINGTON, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its financial results for the first quarter ended March 31, 2026.

LEXINGTON, Mass., May 06, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release first quarter 2026 financial results after the market close on Wednesday, May 13, 2026.